Ovarian

Ovarian - most related articles:

- Obesity linked to ovarian cancer risk - 5.5
- Hormone therapy may increase ovarian cancer risk - 5.2
- Oral contraceptive pills can protect against ovarian cancer - 4.9
- Fertility drugs do not increase ovarian cancer risk - 4.7
- Increasing height and body mass index linked to ovarian cancer risk - 4.7
- Simple blood test may detect ovarian cancer early - 4.4
- Symptoms have little value to diagnose ovarian cancer earlier - 4.4
- Blood & ultrasound can diagnose ovarian cancer early - 4.3
- Initial trials on new ovarian cancer tests exhibit extremely high accuracy - 4.2
- Designing an effective test to detect ovarian cancer - 3.9

Ovarian articles

Increasing height and body mass index linked to ovarian cancer risk
Increasing height and, among women who have never taken menopausal hormone therapy, increased body mass index are risk factors for developing ovarian cancer in women, revealed by researchers.

Antibody may cure variety of human cancers
Human tumors transplanted into laboratory mice disappeared or shrank when scientists treated the animals with a single antibody. This antibody works by masking a protein flag on cancer cells that protects them from macrophages and other cells in the immune system.

Breast cancer vaccine reduces tumours in mice
Researchers have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases-including those that are resistant to common treatments.

Therapy reduces early menopause for women with breast cancer
Temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer, according to a study in the July_20 issue of JAMA.

Ovarian cancer screening does not improve survival
In a clinical trial that included nearly 80,000 women, those who received ovarian cancer screening did not have a reduced risk of death from ovarian cancer compared to women who received usual care, but did have an increase in invasive medical procedures and associated harms as a result of being screened.

New class of cancer drugs could work in colon cancers with genetic mutation
A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study from the University of Michigan Comprehensive Cancer Center finds.

Preventive surgeries better in breast or ovarian cancer patients
A long-term study of women with a genetic predisposition for breast or ovarian cancer showed that those who elected major preventive surgeries had a significantly reduced risk of those cancers.

Preventive cancer surgeries save women's lives
A new study underscores the importance for women with a family history of breast or ovarian cancer to get genetic counseling and testing for the BRCA1 and BRCA2 genes that make them more likely to develop lethal breast or ovarian cancer, says a Northwestern Medicine oncologist.

Initial trials on new ovarian cancer tests exhibit extremely high accuracy
Scientists at the Georgia Institute of Technology have attained very promising results on their initial investigations of a new test for ovarian cancer. Using a new technique involving mass spectrometry of a single drop of blood serum, the test correctly identified women with ovarian cancer in 100 percent of the patients tested. The results can be found online in the journal Cancer Epidemiology, Biomarkers, & Prevention Research.

Simple blood test may detect ovarian cancer early
Researchers find out that CA-125 protein may help detact ovarian cancer in its early stage. The findings were presented by Karen Lu, M.D., professor in MD Anderson's Department of Gynecologic Oncology, in advance of the American Society of Clinical Oncology (ASCO) annual meeting.

Isolated DNA Claims are Not Patentable, US
A federal judge on Monday struck down patents on two genes -- BRCA1 and BRCA2 -- linked to breast and ovarian cancer. Shares of Myriad Genetics (MYGN.O) fell as much as 7 percent, a day after the ruling.

Symptoms have little value to diagnose ovarian cancer earlier
Use of symptoms to trigger a medical evaluation for ovarian cancer does not appear to detect early-stage ovarian cancer earlier and would likely result in diagnosis in only 1 out of 100 women in the general population with such symptoms, revealed in an article.

Biomarkers for ovarian cancer rise a year before diagnosis
Concentrations of the biomarkers CA125, human epididymis protein 4 (HE4), and mesothelin began to rise 3 years before clinical diagnosis of ovarian cancer, according to a new study published online December 30 in the Journal of the National Cancer Institute.

Women opt surgery to remove breasts, ovaries to reduce cancer risk
Many women at high risk for breast or ovarian cancer are choosing to undergo surgery as a precautionary measure to decrease their cancer risk, revealed by US researchers.

Designing an effective test to detect ovarian cancer
Current diagnostic tests for ovarian cancer are woefully ineffective for early detection of the disease, say researchers at Stanford University School of Medicine.

Hormone therapy may increase ovarian cancer risk
Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer.

New technique could save women's fertility
Researchers have successfully grown a woman's immature egg cells, contained in a tiny sac called a follicle, to a healthy and nearly mature egg in the laboratory. When an egg is fully mature, it is ready to be fertilized.

PCOS gets better with acupuncture and exercise
Exercise and electro acupuncture treatments can reduce sympathetic nerve activity in women with polycystic ovarian syndrome (PCOS), revealed by researchers.

Genetic code mistake causes ovarian cancer
Eureka! Vancouver scientists from the Ovarian Cancer Research (OvCaRe) Program at BC Cancer Agency and Vancouver Coastal Health Research Institute have discovered that there appears to be a single spelling mistake in the genetic code of granulosa cell tumours, a rare and often untreatable form of ovarian cancer.

AMP joins ACLU to challenge BRCA gene patents
The Association for Molecular Pathology (AMP) announced that it is working with the American Civil Liberties Union (ACLU) and the Public Patent Foundation to bring a lawsuit charging that patents on two human genes associated with breast and ovarian cancer are unconstitutional and should be invalidated.

$51 million for cancer research in US
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 143 national research and training grants totaling more than $51 million in the second of two grant cycles for 2009. The grants go into effect beginning July 1, 2009.

Blood & ultrasound can diagnose ovarian cancer early
Blood test combined with ultrasound scan can diagnose ovarian cancer (gynecological cancer) early in postmenopausal women, almost 2 years earlier than normal, reported by the British researchers in the Lancet.

Fertility drugs do not increase ovarian cancer risk
The use of fertility drugs does not increase a woman's risk of developing ovarian cancer, finds a large study from Danish researchers published on bmj.com.

Obesity linked to ovarian cancer risk
A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight.

Vitamin C injections slow tumor growth
High-dose injections of vitamin C, also known as ascorbate or ascorbic acid, reduced tumor weight and growth rate by about 50 percent in mouse models of brain, ovarian, and pancreatic cancers, researchers from the National Institutes of Health (NIH) report in the August 5, 2008, issue of the Proceedings of the National Academy of Sciences.

Researchers identify protein that fuels ovarian cancer
A protein that stimulates blood vessel growth worsens ovarian cancer, but its production can be stifled by a tiny bit of RNA wrapped in a fatty nanoparticle, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the Journal of the National Cancer Institute.

Oral contraceptive pills can protect against ovarian cancer
Use of oral contraceptives during a woman's life-time gives substantial long-term protection against ovarian cancer and the longer they are used, the greater the reduction in risk. These are the conclusions of authors of an Article in this week's edition of The Lancet - a medical journal in the United Kingdom.

27 Ovarian articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.17